Trevena - Stock

Trevena Net Income 2024

Trevena Net Income

-27.42 M USD

Ticker

TRVN

ISIN

US89532E1091

WKN

A1XDSL

In 2024, Trevena's profit amounted to -27.42 M USD, a -31.93% increase from the -40.29 M USD profit recorded in the previous year.

The Trevena Net Income history

YEARNET INCOME (undefined USD)
2028e320.07
2027e118.23
2026e-18.52
2025e-25.57
2024e-27.42
2023-40.29
2022-53.67
2021-51.59
2020-29.37
2019-24.87
2018-30.78
2017-71.87
2016-102.99
2015-50.53
2014-49.73
2013-23.59
2012-15.95
2011-15.88

Trevena Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Trevena, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Trevena from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Trevena’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Trevena. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Trevena’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Trevena’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Trevena’s growth potential.

Trevena Revenue, EBIT and net profit per share

DateTrevena RevenueTrevena EBITTrevena Net Income
2028e806.95 M undefined666.1 M undefined320.07 M undefined
2027e294.84 M undefined208.72 M undefined118.23 M undefined
2026e0 undefined-41.87 M undefined-18.52 M undefined
2025e9.13 M undefined-33.34 M undefined-25.57 M undefined
2024e10,200 undefined-34.04 M undefined-27.42 M undefined
20233.13 M undefined-35.29 M undefined-40.29 M undefined
2022-420,000 undefined-56.38 M undefined-53.67 M undefined
2021570,000 undefined-51.93 M undefined-51.59 M undefined
20203.07 M undefined-29.49 M undefined-29.37 M undefined
201930,000 undefined-26.47 M undefined-24.87 M undefined
20185.73 M undefined-29.07 M undefined-30.78 M undefined
20170 undefined-68.62 M undefined-71.87 M undefined
20163.75 M undefined-102.28 M undefined-102.99 M undefined
20156.25 M undefined-50.62 M undefined-50.53 M undefined
20140 undefined-49.95 M undefined-49.73 M undefined
2013130,000 undefined-23.35 M undefined-23.59 M undefined
2012810,000 undefined-15.61 M undefined-15.95 M undefined
20112.42 M undefined-15.75 M undefined-15.88 M undefined

Trevena stock margins

The Trevena margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Trevena. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Trevena.
  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Trevena's sales revenue. A higher gross margin percentage indicates that the Trevena retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Trevena's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Trevena's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Trevena's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Trevena. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Trevena's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Trevena Margin History

Trevena Gross marginTrevena Profit marginTrevena EBIT marginTrevena Profit margin
2028e46.56 %82.55 %39.66 %
2027e46.56 %70.79 %40.1 %
2026e46.56 %0 %0 %
2025e46.56 %-365.25 %-280.12 %
2024e46.56 %-333,710 %-268,864.39 %
202346.56 %-1,129.22 %-1,289.25 %
2022819.05 %13,423.81 %12,778.57 %
2021-68.42 %-9,110.53 %-9,050.88 %
202094.14 %-960.59 %-956.68 %
201946.56 %-88,233.33 %-82,900.01 %
201846.56 %-507.33 %-537.17 %
201746.56 %0 %0 %
201646.56 %-2,727.47 %-2,746.4 %
201546.56 %-809.92 %-808.48 %
201446.56 %0 %0 %
201346.56 %-17,961.54 %-18,146.16 %
201246.56 %-1,927.16 %-1,969.14 %
201146.56 %-650.83 %-656.2 %

Trevena Aktienanalyse

What does Trevena do?

Trevena Inc is an international company specializing in drug development. It was founded in 2007 and is headquartered in Pennsylvania, USA. The history of Trevena begins with the discovery of G-protein coupled receptors (GPCRs), a group of proteins responsible for various biological processes in the body. The founders of Trevena recognized that blocking these receptors could contribute to pain relief and other diseases. With this knowledge, Trevena embarked on comprehensive research and development to develop new drugs. Trevena's business model is based on the development of drugs based on GPCR blockers. The company aims to specifically target diseases for which there is currently no satisfactory therapy. In close collaboration with leading scientists and doctors worldwide, Trevena's researchers and developers are working on the development of innovative drugs for a wide range of diseases. Trevena is divided into different divisions that focus on the development of drugs for different disease areas. These include pain therapy, cardiovascular diseases, and respiratory diseases. One of Trevena's most well-known products is their pain therapeutic Olinvyk (Oliceridine), which is approved for use in patients with moderate to severe pain. The drug is a GPCR blocker that works faster than other painkillers and has minimal side effects. Olinvyk is used in postoperative pain therapy and has the potential to reduce the use of opioids. Another promising drug from Trevena is TRV027, which was developed to treat cardiovascular diseases. The drug aims to reduce the effects of heart attacks and other cardiovascular events and has shown promising results in clinical studies. Trevena is constantly striving to intensify its research and development efforts and expand its product range. The company works closely with regulatory authorities worldwide to ensure the safety and efficacy of its drugs and achieve fast market approval. Overall, the company has made significant progress in recent years and has already brought several drugs to market that have the potential to significantly improve healthcare. The future of Trevena looks promising and holds hope for further innovative drugs. Trevena ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Trevena's Profit Margins

The profit margins of Trevena represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Trevena's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Trevena's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Trevena's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Trevena’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Trevena Stock

How much profit has Trevena made this year?

Trevena has made -27.42 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -31.93% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Trevena publish its earnings?

Trevena publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Trevena?

The profits of Trevena are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Trevena?

You can learn more about the earnings of Trevena by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Trevena pay?

Over the past 12 months, Trevena paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Trevena is expected to pay a dividend of 0 USD.

What is the dividend yield of Trevena?

The current dividend yield of Trevena is .

When does Trevena pay dividends?

Trevena pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Trevena?

Trevena paid dividends every year for the past 0 years.

What is the dividend of Trevena?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Trevena located?

Trevena is assigned to the 'Health' sector.

Wann musste ich die Aktien von Trevena kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Trevena from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Trevena pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Trevena in the year 2023?

In the year 2023, Trevena distributed 0 USD as dividends.

In which currency does Trevena pay out the dividend?

The dividends of Trevena are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Trevena

Our stock analysis for Trevena Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trevena Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.